Cargando…
Hormone replacement therapy benefits meibomian gland dysfunction in perimenopausal women
Meibomian gland dysfunction (MGD) is believed to be the leading cause of dry eye (DE) disease worldwide. The connection between aging and MGD has long been recognized. However, few studies have addressed the relationship between MGD and hormone replacement therapy (HRT) in perimenopausal women, and...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979784/ https://www.ncbi.nlm.nih.gov/pubmed/27495030 http://dx.doi.org/10.1097/MD.0000000000004268 |